Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q3 2023
Institutional positions in Aspire Biopharma Holdings, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q2 2023
- Shares held
- 9.39M
- −354.4K (−3.6%) vs. Q2 2023
- Total value
- $494.7K
- +$4.17K (+0.9%) vs. Q2 2023
- New holders
- 2
- 3 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cohanzick Management, LLC | 166,667 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 10 | $1 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 453 | $23 | 0.00% | +453 | New |
| Athos Capital Ltd | 21,383 | $232 | 0.14% | −3,616−14.5% | Reduced |
| Bulldog Investors, LLP | 12,500 | $634 | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 12,500 | $634 | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $1.25K | 0.00% | 00.0% | Unchanged |
| EHP Funds Inc. | 25,000 | $1.27K | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 25,000 | $1.27K | 0.00% | +25,000 | New |
| Susquehanna International Group, LLP | 26,350 | $1.32K | 0.00% | −7,583−22.3% | Reduced |
| Walleye Trading LLC | 26,190 | $1.33K | 0.00% | +8,190+45.5% | Added |
| Walleye Capital LLC | 46,560 | $2.36K | 0.00% | +14,560+45.5% | Added |
| Atalaya Capital Management LP | 50,000 | $2.50K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 54,499 | $2.76K | 0.00% | −20.0% | Reduced |
| Picton Mahoney Asset Management | 50,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Caas Capital Management LP | 75,000 | $3.80K | 0.00% | 00.0% | Unchanged |
| Flow State Investments, L.P. | 96,168 | $4.88K | 0.00% | +36,168+60.3% | Added |
| Kim, LLC | 100,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| HGC Investment Management Inc. | 100,000 | $5.07K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 125,000 | $6.34K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 125,000 | $6.34K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $7.02K | 0.00% | 00.0% | Unchanged |
| Sage Rock Capital Management LP | 160,076 | $8.12K | 0.01% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 163,800 | $8.12K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 175,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 187,080 | $9.35K | 0.01% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 199,999 | $10.0K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 150,000 | $10.9K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 350,000 | $17.7K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $20.4K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 432,757 | $21.6K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 500,000 | $24.8K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $27.4K | 0.00% | – | – |
| CNH Partners LLC | 647,633 | $32.4K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 899,999 | $44.6K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $49.9K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $53.2K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 1,461,965 | $74.1K | 0.01% | 00.0% | Unchanged |
| Kepos Capital LP | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −14,999−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −62,605−100.0% | Sold out |